Chroma ATE AAQS
The The AAQS of Chroma ATE (2360.TW) as of Nov 19, 2026 is 10. In the previous year, The AAQS was 10.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
10
YoY
0.00%
Last updated:
Chroma ATE has a current AAQS of 10.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Chroma ATE in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Chroma ATE in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Chroma ATE AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2018
10.00 TWD
Jan 1, 2019
10.00 TWD
Jan 1, 2020
10.00 TWD
Jan 1, 2021
10.00 TWD
Jan 1, 2022
10.00 TWD
Jan 1, 2023
10.00 TWD
Jan 1, 2024
10.00 TWD
Jan 1, 2025
10.00 TWD
| YEAR | AAQS | YoY |
|---|---|---|
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | 0.00% | |
| 10 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Chroma ATE Stock analysis
What does Chroma ATE do? Chroma ATE Inc was founded in 1984 and is headquartered in Taiwan. The company is globally recognized as a leading provider of test and measurement equipment for the electronics industry, and its products are used in the semiconductor, electronics, automotive, and battery industries.
Chroma ATE's business model is to offer its customers a wide range of solutions for various testing and measurement requirements. These solutions include hardware and software for automation, measurement technology, power supply, video and color measurement, as well as testing and measurement equipment for electronics production.
The company is divided into different divisions specialized in different testing specifications. The main divisions are Automotive Test Systems, Electronic Test and Measurement, Battery Test and Formation, and Medical and Health Care.
The Automotive Test Systems division of Chroma ATE provides test and measurement solutions for electronic and electrical components in vehicles. This includes high voltage power test systems, battery test systems, chargers, and emulators for various engines and controllers.
The Electronic section of Chroma ATE offers test and measurement equipment for semiconductor products, such as automated IC test systems, wafer testers, in-circuit test systems, functional test systems, and flying probe testers.
The Battery Test and Formation division of Chroma ATE specializes in battery-powered electronics and develops specialized test systems tailored to the requirements of the battery industry. This includes battery characterization devices, lifetime test systems, automated test systems, and fast chargers.
The Medical and Health Care division of Chroma ATE develops and manufactures devices for medical diagnostics and imaging, as well as health monitoring. This also includes test and measurement equipment specifically designed for monitoring electromedical devices.
Chroma ATE prides itself on offering its customers high-quality products and excellent customer service. The company is committed to integrating the latest technologies and innovations to deliver the best solution for its customers' needs. Chroma ATE is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Chroma ATE stock
The AAQS of Chroma ATE is 10 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Chroma ATE since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Chroma ATE
All Key Metrics — Chroma ATE
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth